MARÍA PILAR
GARCÍA ALFONSO
Profesora asociada de Ciencias de la Salud
Christie Hospital NHS Foundation Trust
Mánchester, Reino UnidoPublications in collaboration with researchers from Christie Hospital NHS Foundation Trust (5)
2022
-
First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study
British Journal of Cancer, Vol. 126, Núm. 11, pp. 1548-1554
2020
-
Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study
Annals of Oncology, Vol. 31, Núm. 9, pp. 1160-1168
2019
2018
-
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
The Lancet, Vol. 392, Núm. 10142, pp. 123-133
2003
-
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: Safety results of a randomized, phase III trial
Annals of Oncology, Vol. 14, Núm. 12, pp. 1735-1743